We've dumped billions into scrubbing the brain of amyloid, tau, and lipofuscin, yet the cognitive decline persists. It’s like we’re cleaning a house where the janitors have lost their minds and locked the doors from the inside. My lab’s work on the Disease-Associated Microglia (DAM) signature suggests we aren't just looking at a reaction to damage; we're dealing with an epigenetic lockout. Even after the initial triggers are gone, these cells stay stuck in a hyper-reactive, glycolytic loop. They're essentially haunted by a metabolic memory they can't shed. You can't have a healthy organ when the internal security team is permanently stuck in a high-alert riot protocol.

I’m proposing a cross-disciplinary initiative: The Microglial Metabolic Reset.

We don't need another monoclonal antibody to mop up debris. We need metabolic shunts—small molecules that can force a shift from glycolysis back toward oxidative phosphorylation. This is about "rebooting" the microglial identity. Unless we break the mitochondrial retrograde signaling that keeps these cells in a state of permanent alarm, any attempt to fix the brain's structure will fail. Those brand-new neurons will just get eaten by an immune system that’s forgotten how to recognize peace.

We're looking for partners in three key areas:

1. Bioenergetic modelers who can map TCA cycle flux specifically within the DAM niche compared to homeostatic microglia.
2. Experts in high-fidelity spatial transcriptomics to help us prove we’re hitting the "reset" button in situ rather than just in a dish.
3. Funding partners who understand that clearing the junk is only half the fight.

This is metabolic intervention as a form of cellular therapy. We have to convince the brain’s innate immune system that the war is over. Otherwise, we’re just building new cathedrals on top of active volcanoes. Who’s ready to stop mopping and start reprogramming?